Azenta, Inc.AZTAEarnings & Financial Report
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Revenue
$150.6M
Gross Profit
$68.5M
Operating Profit
$-4.6M
Net Profit
$-6.6M
Gross Margin
45.5%
Operating Margin
-3.1%
Net Margin
-4.4%
YoY Growth
156.3%
EPS
$-0.25
Financial Flow
Azenta, Inc. Q4 2024 Financial Summary
Azenta, Inc. reported revenue of $150.6M (up 156.3% YoY) for Q4 2024, with a net profit of $-6.6M (down 321.6% YoY) (-4.4% margin). Cost of goods sold was $82.1M, operating expenses totaled $73.1M.
Key Financial Metrics
| Total Revenue | $150.6M |
|---|---|
| Net Profit | $-6.6M |
| Gross Margin | 45.5% |
| Operating Margin | -3.1% |
| Report Period | Q4 2024 |
Revenue Breakdown
Azenta, Inc. Q4 2024 revenue of $150.6M breaks down across 2 segments, led by Sample Management Solutions at $84.8M (56.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sample Management Solutions | $84.8M | 56.3% |
| Multiomics | $66.0M | 43.8% |
Azenta, Inc. Revenue by Segment — Quarterly Trend
Azenta, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Sample Management Solutions and Multiomics) has evolved quarter over quarter.
| Segment | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|
| Multiomics | $67.2M | $73.2M | $66.2M | $63.5M |
Azenta, Inc. Annual Revenue by Year
Azenta, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $593.8M).
| Year | Annual Revenue |
|---|---|
| 2025 | $593.8M |
| 2024 | $573.4M |
| 2023 | $551.5M |
| 2022 | $555.5M |
Azenta, Inc. Quarterly Revenue & Net Profit History
Azenta, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 2026 | $148.6M | +0.8% | $-15.4M | -10.4% |
| Q4 2025 | $159.2M | +5.7% | $50.9M | 32.0% |
| Q3 2025 | $143.9M | -0.3% | $-48.0M | -33.4% |
| Q2 2025 | $143.3M | +5.1% | $-47.7M | -33.3% |
| Q1 2025 | $147.4M | +3.7% | $-11.0M | -7.5% |
| Q4 2024 | $150.6M | +156.3% | $-6.6M | -4.4% |
| Q3 2024 | $144.3M | -13.0% | $-6.6M | -4.5% |
| Q2 2024 | $136.4M | -8.1% | $-137.4M | -100.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $136.4M | $144.3M | $150.6M | $147.4M | $143.3M | $143.9M | $159.2M | $148.6M |
| YoY Growth | -8.1% | -13.0% | 156.3% | 3.7% | 5.1% | -0.3% | 5.7% | 0.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.56B | $2.32B | $2.10B | $2.04B | $2.03B | $2.02B | $2.06B | $2.07B |
| Liabilities | $340.6M | $332.9M | $332.4M | $322.6M | $338.6M | $346.0M | $332.6M | $359.6M |
| Equity | $2.22B | $1.99B | $1.77B | $1.72B | $1.70B | $1.67B | $1.73B | $1.71B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $8.7M | $9.8M | $17.7M | $29.8M | $14.4M | $25.8M | $2.2M | $20.8M |